Neuroclues
Founded 2020 · 34 employees on LinkedIn · 3 known investors
neuroClues develops a portable, CE-marked Class IIa eye-tracking device that records eye movements at high frame rates and uses AI algorithms to compute objective biomarkers, helping neurologists with differential diagnosis of parkinsonian syndromes and cerebellar assessment. The platform is aimed at clinical practice in hospitals and neurology clinics across Europe.
Founders & leadership
Board
BB
Bas BloemFounder (Radboudumc Center of Expertise for Parkinson's & Movement Disorders)
Investors · 3
Frequently asked questions
- What does Neuroclues do?
- neuroClues develops a portable, CE-marked Class IIa eye-tracking device that records eye movements at high frame rates and uses AI algorithms to compute objective biomarkers, helping neurologists with differential diagnosis of parkinsonian syndromes and cerebellar assessment. The platform is aimed at clinical practice in hospitals and neurology clinics across Europe.
- Who are Neuroclues's investors?
- Neuroclues's investors include Graph Ventures, Teampact.ventures, White Fund.